<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108411-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Comprendre les m&#xE9;canismes biologiques de la maladie &#xE0; virus Zika</narrative>
   <narrative xml:lang="EN">Understanding the biological mechanisms of Zika virus disease</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Le virus Zika est un pathog&#xE8;ne humain transmis par des moustiques qui s&#x2019;est r&#xE9;pandu dans plus de 50 pays &#xE0; ce jour. Seulement qu&#x2019;au Br&#xE9;sil, on a enregistr&#xE9; deux millions d&#x2019;infections et 4 000 cas pr&#xE9;sum&#xE9;s de malformations cong&#xE9;nitales li&#xE9;es au virus Zika. Malheureusement, aucun antiviral ni vaccin n&#x2019;est actuellement accessible.

Le virus Zika est un pathog&#xE8;ne singulier dot&#xE9; d&#x2019;un complexe profil pathog&#xE9;nique et de transmission. Il peut se transmettre par les moustiques, par les rapports sexuels et entre la m&#xE8;re et l&#x2019;enfant. Il cause un vaste spectre de maladies allant de l&#x2019;infection asymptomatique ou pr&#xE9;sentant peu de sympt&#xF4;mes &#xE0; l&#x2019;infection grave exigeant l&#x2019;hospitalisation. De plus, l&#x2019;infection &#xE0; virus Zika chez les femmes enceintes a &#xE9;t&#xE9; li&#xE9;e &#xE0; la microc&#xE9;phalie et &#xE0; d&#x2019;autres anomalies du d&#xE9;veloppement du foetus et du nouveau-n&#xE9;. Les r&#xE9;gions du Br&#xE9;sil touch&#xE9;es par Zika enregistrent un taux sans pr&#xE9;c&#xE9;dent de malformations cong&#xE9;nitales. La complexit&#xE9; et la gravit&#xE9; de ce virus montrent qu&#x2019;il faut effectuer davantage de recherche pour comprendre les m&#xE9;canismes mol&#xE9;culaires qui permettent au virus Zika d&#x2019;infecter le corps humain, d&#x2019;y persister et de se propager par des cas humains d&#x2019;infection.

Ce projet aura recours &#xE0; des techniques biomol&#xE9;culaires, g&#xE9;nomiques et prot&#xE9;omiques avanc&#xE9;es pour expliquer les m&#xE9;canismes mol&#xE9;culaires permettant au virus Zika d&#x2019;infecter le corps humain et d&#x2019;y persister et la mani&#xE8;re dont il endommage le syst&#xE8;me reproducteur humain et le syst&#xE8;me nerveux central et les moyens de pr&#xE9;dire le risque d&#x2019;anomalies cong&#xE9;nitales chez les femmes enceintes infect&#xE9;es. Le projet peut ainsi permettre de trouver des possibilit&#xE9;s de th&#xE9;rapies pour pr&#xE9;venir les maladies graves chez les m&#xE8;res et leurs nouveau-n&#xE9;s et pour r&#xE9;duire la transmission sexuelle.</narrative>
   <narrative xml:lang="EN">The Zika virus is an emerging mosquito-transmitted human pathogen which has affected over 50 countries to date. More than two million infections and 4,000 suspected cases of Zika virus-related birth defects have been recorded in Brazil alone. Unfortunately, there are no antivirals or vaccines currently available.

The Zika virus is a unique pathogen with a complex transmission and pathogenic profile. It can be spread through mosquitoes as well as via sexual and mother-to-child transmission. It causes a wide spectrum of disease, ranging from symptom-free infections to mild, self-limiting symptoms, to severe infections requiring hospitalization. Additionally, Zika infection in pregnant women has been linked to microcephaly) and other brain abnormalities in developing fetuses and newborn infants. Zika-affected areas in Brazil have shown an unprecedented rise in birth defects. The complexity and severity of this virus underscores the need for greater research to understand the molecular mechanisms which allow the Zika virus to infect, persist, and spread through infected human cases.

This project will use advanced biomolecular, genomics and proteomics techniques to explain the molecular mechanisms by which the Zika virus infects and persists in the human body, how it affects the human reproductive and central nervous system, and how the risk of fetal abnormalities can be better predicted in infected pregnant women. By doing so, the project may identify new opportunities for developing therapies to prevent severe illness in mothers and their infants, and to reduce sexual transmission</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="4" type="22">
   <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
  </participating-org>
  <participating-org role="2" type="23">
   <narrative xml:lang="PT">Funda&#xE7;&#xE3;o para o Desenvolvimento Cient&#xED;fico e Tecnol&#xF3;gico em Sa&#xFA;de</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2017-03-01" type="2"></activity-date>
  <activity-date iso-date="2020-09-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-region code="489" percentage="100" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-03-30"></transaction-date>
   <value currency="CAD" value-date="2017-03-30">506000</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-03-30"></transaction-date>
   <value currency="CAD" value-date="2017-03-30">506000</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-03-31"></transaction-date>
   <value currency="CAD" value-date="2017-03-31">158600</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-02-02"></transaction-date>
   <value currency="CAD" value-date="2018-02-02">100000</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-12-12"></transaction-date>
   <value currency="CAD" value-date="2018-12-12">173800</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-04-20"></transaction-date>
   <value currency="CAD" value-date="2020-04-20">24724</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-10-13"></transaction-date>
   <value currency="CAD" value-date="2020-10-13">-9286</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="PT">Funda&#xE7;ao Oswaldo Cruz- FIOCRUZ</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="0"></conditions>
 </iati-activity>
</iati-activities>
